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Purpose: To determine the combined effects of benzalkonium chloride (BAK) and 
ultraviolet radiation (UV) using the primary culture of intact bovine lenses.  
Methods: Abattoir-provided lenses were dissected from the eyes of cattle age 2 to 3 years. 
Lenses received one of three treatments: BAK, UV, or BAK followed by UV exposure. 
BAK-treated lenses received 10 minutes of exposure to a test solution prepared at 0.01%, 
0.005%, or 0.001% concentration with PBS. Irradiated lenses were treated for 1.5h at a 
measured irradiance of 11.32411 W·m-2 (280-400 nm). Lenses receiving the combined 
treatment underwent the BAK treatment condition followed by UV irradiation. The effects 
were measured using the alamarBlue metabolic activity assay (n=8), and the ScanTox laser-
scanning system to assess optical quality (n=6). PBS exposure served as the control 
treatment. Assessments of metabolic activity were performed on days 0, 2, and 7 following 
exposure. Optical quality was assessed on days 0, 2, 7, 14, 16, 18, and 20.  
Results: BAK-induced toxicity was concentration-dependent. Treatment with BAK 0.01% 
and 0.005% resulted in reduced lens metabolic activity on day 2 and day 7, respectively 
(p<0.05). Optical quality was significantly reduced for 0.01% BAK-treated lenses on day 7 
(p<0.05). For UV-treated lenses, reduced metabolic activity was observed on day 2, while 
optical quality was significantly diminished on day 14 (p<0.05). Combined treatment 
reduced lens metabolic activity and optical quality (p<0.05). Effects were demonstrated 
earlier with the increasing concentration of BAK. However, the combined effects of BAK 
and UV were not significantly different from BAK alone for metabolic activity, or from UV 
alone for optical quality (p>0.05).  
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Conclusion: The combined effects of BAK and UV were not significantly different from the 
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1.1 The eye and the lens 
The vertebrate eye is a sensory organ specially adapted for the perception of light to facilitate 
navigation in the physical environment. In humans, the eye is organized into three layers: the 
outermost fibrous tunic, the middle vascular tunic, and the inner nervous tunic.1 The 
continuous outer tunic is comprised of the densely fibrous sclera, the limbus, and the 
transparent cornea. The vascular tunic includes the iris, ciliary body, and the choroid. The 
nervous tunic consists of the retina.1 The eye is additionally structured into three 
compartments; anterior, posterior, and vitreous. The anterior chamber is formed by the 
anterior boundary of the cornea, and by the iris and lens at the posterior. The posterior 
chamber is defined as the space between the back of the iris and surrounding the lens.1 
Aqueous humor circulates through the anterior and posterior compartments as a means of 
distributing nutrients and removing waste for nearby structures. The vitreous chamber, 
located behind the lens, and extending to the retina, contains the vitreous humor.1  
Incident light rays passing into the eye are converted to electrical signals by the 
photoreceptors which are subsequently interpreted by the central nervous system. The 
passage of light through the eye begins at the cornea, a transparent structure which focuses 
light toward the retina.1 Light travels through the aqueous anterior chamber and its intensity 
is controlled by the iris, which modifies the size of the pupil opening. Light is further focused 
by the lens through the vitreous toward the retina.1 The vertebrate retina is inverted, such that 
the photoreceptors are located beyond the other sensory retinal layers. Photoreceptors are 
responsible for the conversion of the light to an electrical signal.1 The signal is carried 
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through the visual pathway from the retina to the optic nerve for processing by the lateral 
geniculate nucleus, as well as the primary visual cortex in the occipital lobe and other 
association areas.1 
The ocular lens is a biconvex structure. Its molecular composition is largely protein, 
both insoluble and soluble.2 The insoluble proteins are primarily located in the cellular 
membrane and cytoskeleton. The soluble proteins, namely alpha, beta, and gamma crystallin 
proteins, are densely concentrated in the lens and consequently contribute to lens properties.2 
The cellular composition of the lens is comprised mainly of elongated fiber cells. Fiber cells 
are compactly organized into concentric layers, with ends extending toward the anterior and 
posterior surfaces. The ends of the cells meet at the anatomical sutures of each surface.2 Fiber 
cells are further distinguished into the primary fiber cells, which are present from gestation 
and contained within the central nucleus, and secondary fiber cells, which form the 
surrounding cortex. Secondary fiber cells differentiate from the equatorial region of the lens 
and are continually produced as additional layers for life.2 The anterior epithelial monolayer 
sheathes the anterior face of the lens. The lens capsule, the outer boundary of the lens and 
basement membrane, provides attachment for the zonules of Zinn.2  
Optically, the lens functions with the cornea to focus incident light to the retina.3 It 
additionally alters its shape to adjust to the changing focus necessary to produce a clear 
retinal image, known as accommodation.3 To maintain its optical performance, the lens must 
remain transparent and minimize light scatter.2 A number of conditions contribute to lens 
transparency. The lens is avascular, and is largely devoid of organelles, which would 
contribute to light scatter. Only the lens epithelium and superficial cortical fiber cells contain 
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organelles; consequently these areas are primarily responsible for homeostatic mechanisms, 
including cellular metabolism.2 The lens corrects for differences between the refractive index 
of cell membranes and cytoplasm by having increased densities of protein in the cytoplasm 
of centrally located cells.4 The resulting property is a gradient refractive index, decreasing 
from the center to the periphery.5 This is made possible by the tight, regular arrangement of 
soluble intracellular crystallin proteins. Small intercellular spaces further contribute to lens 
transparency, which are narrower than incident wavelengths.4 Gap junctions between 
adjacent fiber cells enable the distribution of metabolites and ions from metabolically active 
cells to secondary fiber cells.2 
1.2 Embryological development of the lens 
Embryological development of the eye in humans is initiated from the primitive forebrain.2 
After approximately 4 weeks development, the neural tube closes at its rostral end, and two 
optic pits form bilaterally as bumps. Developmental events for the two optic pits occur in 
synchrony.2 Cells forming the optic pit undergo proliferation, producing an increasingly 
large, hollow, and spherical opening: the optic vesicle. The optic stalk forms; a hollow, 
single-layer tube of epithelial cells which connect the optic vesicle to the neural tube.2 Cell 
proliferation of the optic vesicle continues until it reaches the peripheral surface ectoderm. 
This step is critical for the induction of the lens from the surface ectoderm.2 The surface 
ectoderm overlying the optic vesicle thickens, and is referred to as the lens placode. Next, 
both tissues invaginate, producing an ectodermal lens vesicle and progression of the optic 
vesicle to the optic cup.2 Once the lens vesicle completely pinches off from the surface 
ectoderm, it is first referred to as the lens. Development of the optic cup progresses 
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simultaneously; a deep fissure (the choroidal fissure) develops, allowing a blood vessel to 
arise between the optic stalk toward the lens vesicle.2 This blood vessel becomes the hyaloid 
artery, supporting early lens development and eventually contributing to the formation of the 
central retinal artery. Next, the choroidal fissure of the optic cup closes.2 The cells of the 
posterior lens elongate, forming primary lens fiber cells and filling the hollow lumen of the 
lens. These cells eventually lose their organelles to maintain lens transparency.2 At this point, 
lens cells begin the process of differentiation through the synthesis of crystallin proteins. The 
anterior lens cells undergo differentiation as part of continuous lifelong growth of the lens.2 
Some will additionally contribute to the hollow center of the lens, and the rest form 
secondary lens fiber cells. Throughout life the differentiation of the anterior epithelial cells 
into fiber cells adds approximately 20 µm in diameter to the lens per year, or about five new 
shells.2 
1.3 Age-related changes in the lens 
As previously mentioned, the lens grows continuously throughout life. Several changes are 
observed in the lens with increasing age, at both the molecular level and in overall properties 
such as size, shape, and mass.2 Presbyopia, the loss of accommodation, is theorized to be 
age-related due to the accumulation of lens growth.2 The ongoing addition of cell layers 
results in increased lens diameter, thickness, and mass. These changes consequently render 
the lens less capable of inducing curvature.2 Similarly, since the distance from the anterior 
pole to the point of attachment of the zonules does not change over time, as a consequence of 
lens gradual diameter increase, the points of attachment are said to shift anteriorly with 
respect to the equator.2 The lens capsule undergoes age-related changes in thickness 
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distribution, increasing in thickness anteriorly with age.2 The aging lens is observed to have a 
steepening radius of curvature. Optically, a shift toward myopia would be expected.2, 6 
Paradoxically, this is not the case; it is theorized that changes in the refractive index occur 
concurrently to account for the change in power resulting from the surface change.2, 6, 7 Over 
time, oxidative stress or other sources of damage may produce modifications in lens 
crystallins.8 This results in crystallin cross-linking and protein insolubility in the lens. The 
nucleus is particularly subject to these changes.8 Fluorescent chromophores additionally form 
in the lens as a result of accumulated UV exposure, and the production of advanced glycation 
end products (AGEs).8 These changes cumulatively produce reduced transparency and 
coloration of the lens, most notably after age 50.8 Changes of this nature may progress to the 
level of cataract. 
1.4 Cataract 
Cataract is the primary cause of blindness in the world, affecting over 20 million people.9, 10 
The condition is defined by the opacification of the ocular lens, resulting in blurred vision or 
loss of vision.2 Treatment of cataract involves the surgical replacement of the ocular lens.2 
Cataracts are typically classified based on the location of the opacity in the lens; they may be 
cortical, nuclear, and posterior subcapsular.2 Cortical cataracts develop in the cortex, and 
may be additionally categorized as a central or equatorial cataract.2 Nuclear cataracts occur 
within the central core of the lens.2 Posterior subcapsular cataracts develop in the superficial 
cortex at the posterior pole.2 Cataracts additionally vary in size, shape, density, and colour, 
introducing uncertainty as to which characteristics are significant to the etiology.2  
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The etiology of cataract is complicated as a result of the large number of common risk factors 
associated with the condition, of both genetic and environmental origin. There are six general 
categories of risk factors for cataract: social and personal factors, diabetes, diarrhea, 
antioxidants, drugs, and UV radiation.2 Examples of social and personal risk factors include 
hypertension, gender, smoking, and alcohol consumption. It is likely that interaction effects 
between risk factors contribute to the cause of cataract.2 Consequently, cataract is regarded as 
a multifactorial condition.2 The most common cause of cataract is age-related change.2 As 
previously mentioned, many age-related changes in the lens are attributable to the lifetime 
accumulation of UV exposure. It follows that UV exposure likely accelerates the 
mechanisms involved in age-related cataract. 
1.5 Ultraviolet radiation 
The solar light spectrum includes UV radiation (100-400 nm), the visible light spectrum 
(400-700 nm), and infrared radiation (700-10 000 nm). The atmospheric ozone layer 
effectively filters UVC radiation (100-280 nm), while some UVB (280-315 nm), and UVA 
radiation (315-400 nm) passes through.11, 12 Recently, the amount of UVB penetration to the 
Earth’s surface due to stratospheric ozone layer depletion has been of concern.13  
Along with the cornea and retina, the lens is one of the most important ocular 
structures vulnerable to incident optical radiation damage.14 A study of UV-irradiated lens, 
corneal, and retinal cell lines suggests that lens epithelial cells are particularly vulnerable to 
UV.14 As previously mentioned, ultraviolet radiation exposure is an established risk factor for 
cataract formation. The lens is reported to absorb much of the radiation from 300 to 400 
nm.15, 16 UV-induced damage to the lens can be produced from either direct or indirect 
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mechanism.17 Direct cataract induction involves the absorption of UV radiation by cellular 
chromophores, such as nucleic acids and proteins.13, 17 For example, alteration and 
aggregation of lens crystallins has been noted as a direct impact of UVB irradiation 
contributing to lens opacities.18 In addition, UV-induced deoxyribonucleic acid (DNA) 
damage has been confirmed through chromatin condensation and fragmentation, as well as 
the ill-timing of DNA synthesis and repair mechanisms.18, 19 The indirect mechanism 
involves the generation of reactive oxygen species (ROS) and free radicals.13, 17 It is reported 
that UVB damages DNA through the direct pathway, while UVA damages DNA through the 
indirect pathway.14 
1.6 Benzalkonium chloride 
Ophthalmic formulations, including solutions and ointments, remain the preferred method for 
treating ocular diseases. A preservative is included in order to reduce the risk of microbial 
contamination of the solution and resulting introduction of a potentially sight-threatening 
infection.20, 21 Benzalkonium chloride is the most commonly employed preservative, and is 
typically found in solution within a concentration range of 0.004% to 0.025%.20 Its chemical 
composition is usually a combination of 12 and 14 carbon tail homologs with a cationic head 
group.20 BAK is reported to possess favourable allergic tolerance, solution stability, and 
antimicrobial efficacy as compared to other preservatives.11, 20-23 Its partially hydrophobic 
nature allows BAK to disrupt the cell walls of pathogenic microorganisms and induce cell 




The toxicity of BAK to the ocular surface has been well reported. In vivo, long-term 
exposure to BAK has been shown to disrupt the tear film, cornea, and conjunctiva.20, 21, 24 
The toxic effects of BAK have been notably observed from long-term use of preserved 
formulations.21-23, 25  The discovery that BAK can penetrate to deep ocular structures is 
relatively recent.20 BAK toxicity to the lens has been examined in epidemiological and in 
vitro research, though the specific molecular mechanism of action is yet to be defined. 
Several clinical trials have followed patients treated with preserved anti-glaucoma 
medication and a general increased incidence of cataract occurred against control.26 The 
toxicity of BAK is known to be both concentration and dose-dependent.11, 22 The toxicity of 
BAK to the eye is additionally enhanced with the administration of multiple doses, due to 
sequestering in tissues.20 
1.7 Mechanisms of combined toxicity 
Exposure to multiple sources of toxicity occurs regularly as part of daily living. Two agents 
which produce independent effects in the body may additionally interact with one another. 
When two exposures do interact, the nature of the reaction may be additive, synergistic, 
potentiating, or antagonistic.16 An additive interaction occurs when the outcome of 
combination is summative of independent toxicity.16 Synergistic reactions are said to occur 
when combined toxicities produce consequences which are significantly greater than their 
sum.16  Potentiation occurs when one exposure whose effects are expected to be 
inconsequential are greatly increased with the introduction of another substance.16 
Antagonism is when one substance impedes the action of another.16 
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1.8 Comparison of bovine and human lenses 
The bovine lens shares several anatomical and physiological characteristics with the human 
lens. Both are asymmetric, elliptical structures that attach via zonules to the muscular ciliary 
body.27 The incremental change in the gradient refractive index from center to periphery is 
additionally similar for these species.27 Other work has shown that bovine and human total 
and bound water content in the lens is similar.28 As in other mammalian vertebrates, the 
bovine lens develops from the embryological surface ectoderm.2, 22 One study found that the 
embryonic and early fetal fiber cells of the nucleus were comparable in size and arrangement 
between these species.29 At birth, the sutures of the human lens are Y-shaped, as is seen in 
the bovine lens.30 However, as the human lens develops, the sutures become further 
branched, forming a stellar appearance.30 The sutures in bovine and human lenses have 
implications for accommodation.31 Human lenses are known to perform accommodation. In 
bovine lenses, fiber arrangement at the sutures does not permit overlap, and consequently 
bovine lenses are generally not thought to undergo accommodation.31 One study performed 
in vitro determined with manipulation of the bovine lens that it could theoretically produce 
accommodation of approximately 2 diopters.32 One clear difference between bovine and 
human eyes is that the bovine eye is significantly larger; this is additionally true for lenses. 
The equatorial diameter of bovine lenses is approximately 17 mm,33 as compared to 10 mm 
for the aged human lens.2 Bovine and human lenses are also known to exhibit differences in 
spherical aberration.34 Bovine lenses exhibit no spherical aberration, while in humans 




Cataract is the primary cause of blindness in the world.10 The treatment for the condition is 
surgical replacement of the ocular lens, and represents a significant burden to health care 
systems. This has prompted considerable effort in research to determine the underlying 
causes of the condition. The onset of cataract is abstract because of the large number of risk 
factors and lifelong accumulation of lens damage from sub-threshold exposures.16 Exposure 
to preservatives in ophthalmic formulations and UV radiation are common experiences, and 
each is independently associated with cataract.15, 35 
The Draize test is the most common method for assessing ocular irritancy and 
toxicity.36  In this method, the animal, typically a rabbit, is exposed to the test substance and 
the toxicity on the skin or the eye is observed over time.36 However, there are important 
criticisms of this method to consider. For example, it has been shown to produce variable 
results, and it demonstrates low sensitivity.37, 38 Moreover, the associated animal discomfort 
and pain raises ethical concerns. In vitro assessment of the lens has been suggested as an 
alternative method to test for ocular toxicity.39  The bovine lens has been proposed as a 
suitable in vitro model to assess ocular irritancy due to the similarities in embryology, 
morphology, and physiological properties as the human cornea and lens.22, 27 
Our group has previously developed an in vitro method for assessing the effects of 
BAK toxicity and UVB radiation on the bovine lens.22 The results indicate that, at sufficient 
exposure, BAK and UVB can independently induce lens damage and reduce optical quality.22  
We have also looked at the combined effects of BAK and UV exposure on human corneal 
 
11 
epithelial cells (HCEC), which showed that additive or synergistic effects may occur as a 
result of a combined mechanism.11 To our knowledge, no studies have reported the combined 
effects of BAK and UV on the bovine lens. The results of this study may provide valuable 
insights on the underlying mechanisms leading to cataract formation and prevention, with 




3.1 Ocular dissection and tissue culture 
Bovine eyes, from cows 2-3 years of age, were obtained through a local abattoir (Cargill 
Meat Solutions, Guelph, ON). The eyes were prepared for dissection by immersion in a 
diluted iodine solution.  The dissection of the bovine lens (Figure III-1), performed under 
sterile conditions in a flow hood, has been previously reported.22 The dissections were 
completed approximately 2-5 hours after obtaining the eyes. Eyes with corneal damage or 
scleral puncture as a result of the extraction process were not dissected. First, excess muscle, 
fat, and connective tissue were removed. The posterior half of the eye was then removed, 
followed by the excision of the vitreous humour. The anterior half of the eye was transferred 
to another petri dish and dissected with a separate set of instruments to reduce the risk of 
microbial or fungal contamination of the lens. Subsequently, the iris and ciliary attachments 
were separated from the anterior portion of the globe along with the lens. The zonule 
connections to the lens were then carefully cut, with the final cuts taking place over the 
culture chamber to avoid possible damage to the lens. Lenses were rinsed with culture 
medium to prevent pigmented tissue fragments from adhering to the lens and to reduce 
exposure of the lens to oxygen. Dissection instruments were briefly soaked in 70% ethanol 
between new dissections. A minimum of 18 dissected lenses were cultured to ensure that 12 
samples would meet the standards for dissection quality and to prevent reduction of sample 
size due to contamination or culture chamber leaks. 
The dissected crystalline lenses were cultured in custom two-compartment culture 
chambers, with 21 mL of culture medium. The medium was prepared from 9.4g/L M-199 
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(Sigma-Aldrich, St. Louis, MO), 3% fetal bovine serum (FBS) (Life Technologies, 
Burlington, ON), 1% penicillin/streptomycin (Life Technologies), 0.1g/L L-glutamine 
(Sigma-Aldrich), 7mL/L 1M NaOH (Sigma-Aldrich), 5.96g/L HEPES (N-(2-
Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) hemisodium salt) (Sigma-Aldrich), and 
2.2g/L sodium bicarbonate (Sigma-Aldrich). The medium was sterile-filtered through a 0.2 
µm vacuum filtration system (VWR, Mississauga, ON) prior to the addition of FBS. The 
lenses were incubated at 37oC, in an atmosphere of 5% CO2 and 95% air. Lenses were 
cultured for 48 hours post-dissection and assessed for damage prior to experimental use. 
Lenses damaged due to dissection or contamination were excluded from experimental use. 
The culture medium was aspirated and replenished after lens treatment, and every 48 hours 
during experimentation with the ScanTox assay. During the experiments with alamarBlue, 
culture medium was replaced after the assay was performed, and 48 hours after the previous 
medium replacement. The culture medium was stored at 2-4°C in a refrigerator between uses 
and was warmed to 37°C prior to lens culture. Lenses were inspected at the time of medium 




Figure III-1 The dissection of the bovine eye, performed under sterile conditions. 
Depicted from left to right and top to bottom.  
 
15 
3.2 Exposure methodology 
The study evaluated and compared the effects of three treatments on the bovine lens: (1) 
BAK (2) UV irradiation (3) BAK followed by UV irradiation. The following procedure has 
been adopted from Youn et al.22 
3.2.1 Exposure to BAK 
BAK for this study was diluted from a purchased 50% solution (Sigma-Aldrich) with 
phosphate buffered saline (PBS) (Lonzo, Walkersville, MD). The preparation of BAK 
solution was performed while protecting BAK from direct light. BAK solutions were 
prepared at concentrations of 0.001%, 0.005%, and 0.01% with PBS. These concentrations 
were chosen based on the current clinical use of BAK in ophthalmic formulations. In 
addition, exposure to BAK 0.01% solution for 10 min was determined in preliminary 
experiments to produce approximately 20% reduction in metabolic activity compared to 
control after 7 days. Lenses were oriented in their chambers with the posterior surface resting 
level on the circular beveled washer. Exposure to BAK was performed under sterile 
conditions in a flow hood at room temperature. The culture medium was aspirated from the 
chamber cells, and replaced with 6.5 mL of a BAK test solution. The lenses were exposed to 
the BAK test solution for 10 min. Control lenses were exposed to PBS for 10 min. After the 
treatment period, all lenses were rinsed three times with FBS-free culture medium. The 
chambers were then replenished with 21 mL of culture medium. The lenses were then 
evaluated using the alamarBlue assay (t = 0d, 2d, 7d), or the laser scanner (t = 0d, 2d, 7d, 
14d, 16d, 18d, 20d). After treatment with BAK, lenses were replenished with culture 
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medium, and incubated for 2.5 hours to acclimatize the lens to a change in osmolarity and 
temperature during the experimental procedure, prior to the assessment of optical quality. 
Experiments were performed in triplicate, with n = 3 per treatment condition. 
3.2.2 Exposure to UV 
UV radiation (280-400 nm) exposure was accomplished using a unique UV irradiation 
chamber.11 The UV source used for this study was two UVA and two UVB fluorescence 
tubes (Microlites Scientific, Toronto, ON). The UV source was located approximately 30 cm 
above the sample stage. The UV source was switched on for approximately 15 min prior to 
experimental use. Lenses were irradiated for 1 h 30 min. The irradiance was measured at 
11.32 W·m-2 using a USB 2000+ fiber optic spectrometer (Ocean Optics, Inc., Dunedin, FL). 
The exposure conditions were determined based on pilot experiments. These conditions were 
shown to produce an approximate 20% reduction in metabolic activity as compared to 
control after 7 days. The lenses were irradiated within their culture chambers, oriented such 
that the anterior surface was level and facing toward the UV source. Culture medium was 
aspirated from the culture chamber and replaced with approximately 6.5 mL of FBS-free 
culture medium. A thin layer of medium (approximately 1 mm) was left above the anterior 
surface of the lens left to prevent air exposure and to reduce absorption of UV radiation by 
the medium. The lens chambers were covered with quartz cover slips to allow the passage of 
UV, and to reduce both evaporation of the medium and the potential for contamination of the 
sample. At the half-time point of exposure, the samples were reordered in the irradiation 
chamber to ensure similar exposure to the spectral irradiance for all lenses. 
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The temperature of the irradiation chamber gradually increased from starting room 
temperature, approximately from 24°C to 38°C.  The atmosphere of the irradiation chamber 
was ambient air. Control lenses were placed in a separate incubator with ambient air and 
whose temperature was gradually increased from 24°C to 38°C. After the irradiation interval, 
the lenses were evaluated using the alamarBlue assay (t = 0d, 2d, 7d) and the laser scanner (t 
= 0d, 2d, 7d, 14d, 16d, 18d, 20d). Following irradiation with UV, lenses were replenished 
with culture medium, and incubated for 2.5 hours to acclimatize the lens to a change in 
medium osmolarity and temperature during the experimental procedure, prior to the 
assessment of optical quality. Experiments were performed with n = 6 in each experimental 
group. 
3.2.3 Combined exposure to BAK and UV 
The crystalline lenses were exposed first to a BAK solution, followed by UV irradiation 
using the same procedures detailed above. Control lenses were exposed to the previously 
outlined control conditions for BAK and UV exposure, consecutively. The lenses were 
evaluated using the alamarBlue assay (t = 0d, 2d, 7d) and the laser scanner (t = 0d, 2d, 7d, 
14d, 16d, 18d, 20d). Following the treatment protocol, lenses were replenished with culture 
medium, and incubated for 2.5 hours to acclimatize the lens to a change in osmolarity and 
temperature during the procedure, prior to the assessment of optical quality. Lenses were 
assessed for optical quality prior to medium replacement. Experiments were performed in 
triplicate, with n = 3 per treatment condition. 
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3.3 Analysis of cellular activity 
AlamarBlue (resazurin) is a nontoxic colorimetric and fluorometric assay of cellular activity. 
Viable cells can metabolize the indicator through a redox mechanism to produce an 
absorbance or fluorescence change, proportional to metabolic activity. A higher fluorescence 
reading correlates to higher metabolic activity. Metabolism of the indicator produces a colour 
change from blue to pink (resazurin to resorufin) (Figure III-2). 
For evaluation of metabolic activity, lenses were placed into a sterile clear-bottom 12-
well plate containing 3.8 mL of alamarBlue solution (Life Technologies), prepared at 8% 
with clear FBS-free culture medium. The assay solution was freshly prepared to prevent 
precipitation of the indicator, and protected from direct light, as alamarBlue is light-sensitive. 
The lenses were incubated in the solution for 5h, after which the end-point fluorescence was 
measured using the SpectraMax M5e microplate reader (Molecular Devices, Sunnyvale, 
CA).22 The alamarBlue solution preparation and duration of incubation time were determined 
from previous experiments using porcine and bovine lenses.22, 40 Fluorescence was measured 
at excitation and emission wavelengths at 560 nm and 590 nm, respectively. Following 
incubation, the lenses were replaced into their respective culture chambers and rinsed with 
FBS-free medium warmed to 37°C. Next, lenses were replenished with fresh medium and 
cultured until the next time point measurement. For the fluorescence reading, 100 µL was 
sampled from the 12-well plate for each lens and transferred into a sterile clear-bottom 96-
well plate for measurement. Fluorescence was measured at t = 0d, 2d, 7d (d = days). The t = 
0d time point was defined as the time immediately following exposure to the test condition. 
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All procedures were completed under sterile conditions. A total of 88 lenses were included in 
the metabolic activity study, with n = 8 per experimental condition. 
 
 
Figure III-2 End-point appearance of the alamarBlue assay for control and BAK-
treated lenses. AlamarBlue (blue) is reduced to fluorescent alamarBlue (red) proportional to 
cellular metabolic activity.  
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3.4 Analysis of optical quality 
The assessment of lens optical quality used a custom designed laser scanning system 
(ScanTox, University of Waterloo, Waterloo, ON).22 During the assessment, the lenses 
remained within their two-compartment culture chambers.  The lenses were oriented with the 
anterior surface resting on the plastic beveled washer (diameter = 14 mm). The laser system 
projects light onto a mirror, mounted at a 45 degree angle, which then reflects the light 
through the lens (Figure III-3). The mirror position is altered using a computer-aided 
mechanism, such that the system captures the light passing through the lens at multiple 
positions. A digital video camera, mounted within the scanner, captures the position and 
slope of the refracted beam. Software analysis of this data produces measurements of back 
vertex distance (BVD) variation for each lens.22 Lenses were scanned at 20 eccentricities at 
increments of 0.5 mm, with a range of 10 mm along one axis. Each lens was scanned twice 
along perpendicular axes; single measurements of BVD variability generated by ScanTox II 
software were based on 40 quantitative measurements. The ScanTox experiments consisted 
of 60 lenses, or 6 lenses per experimental group, cultured for 22 days. Individual beams 
passing through the central zone were excluded from the BVD measurement calculations to 
exclude beams passing through lens sutures and provide the most conservative measurement 
of BVD variability. The optical quality was assessed for t = 0d, 2d, 7d, 14d, 16d, 18d, 20d.  
The t = 0d time point was defined as the time 2.5 hours after the exposure period. This time 
was chosen to allow lenses to stabilize following changes in medium osmolarity and 




Figure III-3 Measurement of optical quality. The ScanTox reflects incident beams of light 
through the lens (left) at different eccentricities and calculates the BVD mean and error based 
on the distances behind the lens where the refracted rays intersect with a central axis. 
Optimal optical quality is produced with minimal BVD variability (center), and optical 
quality is increasingly poor as BVD variability is increased (right).  
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3.5 Statistical analysis 
Experimental data was analyzed using two-way repeated measures analysis of variance using 
the GraphPad Prism 7® statistical analysis software program. Analysis was performed 
between experimental groups to determine the effect of different treatments against control 
conditions, as well as within experimental groups to determine changes in lens performance 
over time for a particular treatment. The Bonferroni multiple comparisons post-hoc test was 
performed for both alamarBlue and ScanTox results. Statistical significance was determined 




4.1 Metabolic activity 
The metabolic activity of the cultured bovine lenses following treatment was measured using 
the alamarBlue assay. The assay results produced measurements of fluorescence for each 
lens sample. The fluorescence measurements were proportional to cellular metabolic activity 
within the lens. One of the main challenges of this project was to identify doses of UV and 
BAK that caused intermediate toxicity. Using previous studies11, 22 and pilot studies, it was 
determined that the best preparations of BAK solution were 0.01%, 0.005%, and 0.001% and 
an exposure time of 10 minutes, and a UV exposure time of 90 minutes with a measured 
irradiance of 11.32411 W·m-2. Exposure times that are too extensive would mask the toxicity 
of the second agent and toxicity of little consequence may not provide enough toxicity to 
measure individual toxicities and then the additive effects. Therefore, the results from this 
study look at toxicity of intermediate effects of the both UV and BAK tested. 
As shown in Figure IV-1, treatment of the lenses with BAK, UV, or combined BAK 
and UV resulted in decreased metabolic activity compared to control on day 7. Table IV-1 
additionally shows the decreased activity from the first measurement to the end point 
measurement for each lens. The control (no BAK) lenses that were tested with the BAK 
samples did not experience a significant change in metabolic activity for the experimental 
duration (p > 0.9999). BAK toxicity to the lens demonstrated a concentration-dependent 
response. Exposure to a BAK 0.01% solution resulted in significantly lower metabolic 
activity on day 7 compared to exposure to BAK 0.005% and BAK 0.001% (p = 0.0006; p < 
0.0001).  Lenses treated with a 0.01% BAK solution had significantly lower cellular 
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metabolic activity compared to control (p < 0.0001). The damage caused by the BAK 0.01% 
resulted in metabolic activity 71% ± 9% of the control. The metabolic activity of lenses 
treated with a BAK 0.005% was statistically similar to control on day 0 and day 2, and was 
significantly lower than control on day 7 (p = 0.0115). The damage produced by BAK 
0.005% was 88% ± 6% of control. Lenses treated with a 0.001% BAK solution had 
metabolic activity that was not significantly different from the control at all time points, with 
metabolic activity 91%±6.5% of control (p > 0.05). Additionally, the observable toxicity of 
BAK was time-dependent, such that reduction in cellular metabolic activity compared to 
control was greater at each subsequent time point. For example, lenses treated with 0.005% 
BAK solution, the metabolic activity of the lenses progressed from 93%±5.4% of control on 
day 0, to 91%±7.9% on day 2, to 88%±6% on day 7. Reductions in lens metabolic activity 
persisted through the study period. 
Table IV-1 shows the mean metabolic activity for UV-irradiated lenses (n = 12) as a 
percent of the control (n = 12). The lenses used as a control (no UV) for the UV experiment 
did not demonstrate significant changes in metabolic activity for the experimental duration (p 
> 0.9999). The UV-treated lenses demonstrated significant reductions in mean metabolic 
activity at day 2 (p < 0.0002), and day 7 (p < 0.0001) as compared to control. The metabolic 
activity was reduced to 80%±9% on day 7. The decline in cellular activity also became 
greater with each subsequent time point following exposure. 
Table IV-1 shows the mean metabolic activity of the combined treatment groups as a 
percent of the control. As compared to control, all combined treatment groups showed 
significantly decreased metabolic activity at the day 2 measurement. The adjusted p values 
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on day 2 for the combined treatment groups BAK 0.01% + UV, BAK 0.005% + UV, and 
BAK 0.001% + UV at day 2 were p < 0.001, p = 0.0012, and p = 0.0276, respectively. The 
mean metabolic activity for these groups on day 2 were 72%±12%, 82%±9%, and 87%±11% 
of control, respectively. At day 7, BAK 0.01% + UV, and BAK 0.001% + UV were 
significantly different from control, with metabolic activity 71%±16% and 85%±9% of 
control, respectively. The BAK 0.005% + UV treatment group at day 7 was statistically 
similar to the control (p = 0.0522); the metabolic activity was 88%±12% of the control. 
A two-way analysis of variance was performed to compare independent BAK or UV 
exposure against the combined treatment group (Table IV-2 and Table IV-3, respectively). 
Data analysis was performed with the raw data and additionally normalized to a control. The 
normalized data are presented here. The analyses produced similar results; no significant 
difference was determined between the combined treatment and both individual exposures 
for any treatment during the experiment (p > 0.05). 
There was no statistical difference observed between single exposure BAK-treated 
lenses and combined treatment lenses at any concentration for any time point (p > 0.05) 
(Figures IV-2, IV-3, IV-4). A significant difference in metabolic activity was observed 
between the UV-treated lenses and the BAK 0.01% plus UV-treated lenses at day 2 (p = 
0.0014) (Figure IV-5).  
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Table IV-1 Mean metabolic activity as a percent of the control for all treatment groups. 
All data are reported as mean ± standard deviation. Each experimental condition had an 
independent control. The exposure duration for BAK-treated lenses was 10 min. UV-treated 
lenses were irradiated for 1.5h. Statistical significance was determined based on a p value 
less than 0.05. Statistical difference from control is indicated by *, and † indicates statistical 
difference from the day 0 measurement. 
Alamar blue / Normalized Time 
Experimental Group Day 0 (post-
treatment) 
Day 2 Day 7 
Control (no BAK) (n = 8) 100.0 ± 6.11 100.0 ± 8.12 100.0 ± 8.39 
BAK 0.01% (n = 8) 95.90 ± 8.41 78.50 ± 8.34*† 71.74 ± 9.02*† 
BAK 0.005% (n = 8) 93.0  ± 5.40 91.21 ± 7.87* 88.01 ± 5.99* 
BAK 0.001% (n = 8) 92.73 ± 10.30 94.59 ± 10.39 91.96 ± 6.59 
Control (no UV) (n = 12) 100.0 ± 5.39 100.0 ± 5.30 100.0 ± 5.88 
UV (n = 12) 98.36 ± 5.91 88.35 ± 7.91*† 80.15 ± 9.06*† 
Control (no BAK or UV)  
(n = 8) 
100.0 ± 4.39 100.0 ± 7.21 100.0 ± 10.35 
BAK 0.01% + UV (n = 8) 93.17 ± 5.77 72.77 ± 11.75*† 70.71 ± 16.41*† 
BAK 0.005% + UV (n = 8) 93.12 ± 5.70 82.21 ± 8.76*† 88.31 ± 12.41 




Table IV-2 Comparison of BAK-treated lenses and BAK plus UV-treated lenses. All 
data are reported as mean metabolic activity as a percent of the respective control ± standard 
deviation. 
Alamar blue / Normalized Time 
Experimental Group Day 0 (post-
treatment) 
Day 2 Day 7 
BAK 0.01% (n = 8) 95.90 ± 8.41 78.50 ± 8.34 71.74 ± 9.02 
BAK 0.01% + UV (n = 8) 93.17 ± 5.77 72.77 ± 11.75 70.71 ± 16.41 
BAK 0.005% (n = 8) 93.0  ± 5.40 91.21 ± 7.87 88.01 ± 5.99 
BAK 0.005% + UV (n = 8) 93.12 ± 5.70 82.21 ± 8.76 88.31 ± 12.41 
BAK 0.001% (n = 8) 92.73 ± 10.30 94.59 ± 10.39 91.96 ± 6.59 
BAK 0.001% + UV (n = 8) 96.28 ± 5.80 87.15 ± 10.67 84.86 ± 9.18 
 
Table IV-3 Comparison of UV-treated lenses and BAK plus UV-treated lenses. All data 
are reported as mean metabolic activity as a percent of the respective control ± standard 
deviation. 
Alamar blue / Normalized Time 
Experimental Group Day 0 (post-
treatment)  
Day 2 Day 7 
UV (n = 12) 98.36 ± 5.91 88.35 ± 7.91 80.15 ± 9.06 
BAK 0.01% + UV (n = 8) 93.17 ± 5.77 72.77 ± 11.75* 70.71 ± 16.41 
BAK 0.005% + UV (n = 8) 93.12 ± 5.70 82.21 ± 8.76 88.31 ± 12.41 





Figure IV-1 Mean metabolic activity as a percent of the control for all treatment 
groups. All data are reported as mean ± standard deviation. Each experimental condition had 






Figure IV-2 Mean metabolic activity for independent BAK 0.01% exposure and 
combined treatment with BAK 0.01% plus UV. 
 
Figure IV-3 Mean metabolic activity for independent BAK 0.005% exposure and 




Figure IV-4 Mean metabolic activity for independent BAK 0.001% solution and 
combined treatment with BAK 0.001% plus UV. 
 
Figure IV-5 Mean metabolic activity for independent UV exposure and combined 
treatment with BAK plus UV. 
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4.2 Optical performance 
The concept of applying intermediate toxicity was also used for a second endpoint evaluated 
using the ScanTox method. The doses of BAK and UV administered in the experiments for 
optical quality were adopted from previous work by our group,11, 22 and are consistent with 
those evaluated in the metabolic activity assay. The optical performance of the cultured 
bovine lenses was measured using the ScanTox laser scanning system. The ScanTox 
produces measurements of BVD standard error (SE) to indicate the ability of the lens to 
focus light to a single point behind its posterior surface along a central axis. An increase in 
BVD error indicates reduced optical quality, or the reduced functional ability of the lens to 
focus light. Treatment with BAK, UV, or BAK plus UV generally produced lens damage, 
resulting in increased BVD error (Figure IV-6). 
The toxicity of BAK was observed in the highest experimental concentration of BAK 
(Figure IV-8). Lenses exposed to BAK 0.001% and BAK 0.005% demonstrated BVD 
variability statistically similar to the control group (p > 0.9999). A significant difference was 
apparent in lenses exposed to BAK 0.01% at the day 7 time point (p = 0.0225). The damage 
produced by BAK 0.01% was associated with time such that at each subsequent time point 
the BVD variability increased and optical quality was increasingly poor. The BVD variability 
of lenses between groups and over time is shown in Table IV-4. 
The control lenses (no UV) in the UV experiment did not show a significant change 
in optical quality over the duration of the experiment (p > 0.9999). The effect of the UV 
treatment on optical quality was significantly different from control data at the day 14 time 
point (p < 0.0001). Within this group, the decline in optical quality was also apparent on day 
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14, as compared to day 0 (p < 0.0001). Maximum damage due to UV treatment was observed 
at the day 16 time point (BVD SE = 2.638, p < 0.0001) (Figure IV-5). The lenses showed 
some recovery of BVD variability after day 16. The BVD variability for the UV experiment 
lenses is reported in Table IV-4. 
All lenses receiving combined treatment of BAK and UV demonstrated a significant 
increase in BVD error as compared to controls (p < 0.05) (Figure IV-9). There was no 
significant change in the optical quality in the control lenses during the experiment (p > 
0.9999).  The damage produced by combined treatment followed a dose-response, such that 
lenses exposed to BAK 0.01% plus UV, showed significantly reduced optical quality earlier 
than BAK 0.005% plus UV and BAK 0.001% plus UV. Additionally, the BAK 0.001% plus 
UV-treated lenses showed some recovery at the final time point; BVD variability was not 
significantly greater than the control (p = 0.0780). Lenses treated with BAK 0.01% plus UV 
showed significant reductions in optical quality at day 7 against control (p = 0.0379), which 
persisted to the final time point. Lenses treated with BAK 0.005% plus UV and BAK 0.001% 
plus UV showed significant changes in BVD variability at day 14 (p < 0.0001, p = 0.0001). 
No statistical difference in optical quality was observed between UV-treated lenses 
and the combined treatment groups at any time point (p > 0.05); shown in Table IV-5. 
Similarly, as shown in Table IV-6, lenses treated with BAK 0.01% were statistically 
comparable to the combined group BAK 0.01% plus UV across all time points (p > 0.05). As 
compared to lenses treated with BAK 0.005%, the effect of a combined treatment BAK 
0.005% plus UV produced significantly greater BVD variability from day 14 (p < 0.05). This 
was also true between the treatments of BAK 0.001% and BAK 0.001% plus UV (p < 0.05). 
 
33 
A significant difference between treatment groups was observed only between BAK 
alone and UV alone, at day 14 between BAK 0.001 and UV, and at day 16, between all 
concentrations of BAK and UV (p < 0.05). There was no significant difference between the 
independent and combined treatment groups (p > 0.05) (Figure IV-10, IV-11, IV-12, and IV-
13). 
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Table IV-4 Back vertex distance variability for all groups. All data are reported as mean ± standard deviation. Statistical 
significance was determined based on a p value less than 0.05. Statistical difference from control is indicated by *, and † indicates 
statistical difference from the day 0 measurement. The reported mean and standard deviation values are produced from the average of 
6 lenses evaluated at each time point. 
ScanTox Time 
Experimental Group  
(n = 6) 
Day 0 (post-
treatment) 
Day 2 Day 7 Day 14 Day 16 Day 18 Day 20 
Control (no BAK) 0.340 ± 0.11 0.344 ± 0.07 0.265 ± 0.04 0.314 ± 0.06 0.321 ± 0.07 0.329 ± 0.07 0.364 ± 0.08 
BAK 0.01% 0.365 ± 0.11 0.501 ± 0.07 0.928 ± 0.44*† 1.089 ± 0.82*† 1.214 ± 0.88*† 1.376 ± 1.04*† 1.534 ± 1.41*† 
BAK 0.005% 0.338 ± 0.07 0.318 ± 0.08 0.294 ± 0.06 0.424 ± 0.23 0.376 ± 0.09 0.439 ± 0.18 0.510 ± 0.29 
BAK 0.001% 0.323 ± 0.09 0.343 ± 0.09 0.322 ± 0.11 0.331 ± 0.11 0.336 ± 0.11 0.335 ± 0.08 0.356 ± 0.10 
Control (no UV) 0.340 ± 0.05 0.302 ± 0.04 0.288 ± 0.05 0.281 ± 0.09 0.314 ± 0.08 0.280 ± 0.04 0.349 ± 0.07 
UV 0.262 ± 0.09 0.317 ± 0.12 0.497 ± 0.31 1.536 ± 0.62*† 2.638 ± 1.15*† 1.338 ± 0.46*† 1.472 ± 0.56*† 
Control (no BAK or 
UV) 
0.307 ± 0.08 0.345 ± 0.07 0.305 ± 0.08 0.320 ± 0.07 0.336 ± 0.07 0.330 ± 0.09 0.345 ± 0.09 
BAK 0.01% + UV 0.414 ± 0.14 0.850 ± 0.31 1.503 ± 1.13*† 2.062 ± 1.42*† 1.607 ± 0.93*† 2.420 ± 2.38*† 1.574 ± 0.47*† 
BAK 0.005% + UV 0.344 ± 0.06 0.325 ± 0.07 0.746 ± 0.74 2.382 ± 1.92*† 1.658 ± 0.85*† 1.665 ± 0.83*† 1.587 ± 0.68*† 





Table IV-5 Combined treatment groups compared to UV treatment group. Data are reported as mean ± standard deviation. 
ScanTox Time 
Experimental Group  
(n = 6) 
Day 0 (post-
treatment)  
Day 2 Day 7 Day 14 Day 16 Day 18 Day 20 
UV 0.262 ± 0.09 0.317 ± 0.12 0.497 ± 0.31 1.536 ± 0.62 2.638 ± 1.15 1.338 ± 0.46 1.472 ± 0.56 
BAK 0.01% + UV 0.414 ± 0.14 0.850 ± 0.31 1.503 ± 1.13 2.062 ± 1.42 1.607 ± 0.93 2.420 ± 2.38 1.574 ± 0.47 
BAK 0.005% + UV 0.344 ± 0.06 0.325 ± 0.07 0.746 ± 0.74 2.382 ± 1.92 1.658 ± 0.85 1.665 ± 0.83 1.587 ± 0.68 
BAK 0.001% + UV 0.391 ± 0.35 0.377 ± 0.18 0.440 ± 0.03 2.307 ± 0.98 1.822 ± 0.83 2.130 ± 0.81 1.412 ± 0.29 
Table IV-6 Comparisons of combined treatment groups against individual exposure to BAK for each concentration. All data 
are reported as mean ± standard deviation. Statistical significance, indicated with *, was determined based on a p value less than 0.05. 
ScanTox Time 
Experimental Group  
(n = 6) 
Day 0 (post-
treatment)  
Day 2 Day 7 Day 14 Day 16 Day 18 Day 20 
BAK 0.01% 0.365 ± 0.11 0.501 ± 0.07 0.928 ± 0.44 1.089 ± 0.82 1.214 ± 0.88 1.376 ± 1.04 1.534 ± 1.41 
BAK 0.01% + UV 0.414 ± 0.14 0.850 ± 0.31 1.503 ± 1.13 2.062 ± 1.42 1.607 ± 0.93 2.420 ± 2.38 1.574 ± 0.47 
BAK 0.005% 0.338 ± 0.07 0.318 ± 0.08 0.294 ± 0.06 0.424 ± 0.23 0.376 ± 0.09 0.439 ± 0.18 0.510 ± 0.29 
BAK 0.005% + UV 0.344 ± 0.06 0.325 ± 0.07 0.746 ± 0.74 2.382 ± 1.92* 1.658 ± 0.85* 1.665 ± 0.83* 1.587 ± 0.68* 
BAK 0.001% 0.323 ± 0.09 0.343 ± 0.09 0.322 ± 0.11 0.331 ± 0.11 0.336 ± 0.11 0.335 ± 0.08 0.356 ± 0.10 
BAK 0.001% + UV 0.391 ± 0.35 0.377 ± 0.18 0.440 ± 0.03 2.307 ± 0.98* 1.822 ± 0.83* 2.130 ± 0.81* 1.412 ± 0.29* 
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Figure IV-6 Back vertex distance variability for all experimental conditions. All data are 
reported as mean ± standard deviation. Statistical significance* was determined by a p value 




Figure IV-7 Back vertex distance variability for UV-treated lenses as compared to 
control (no UV). 
 
Figure IV-8 Back vertex distance variability for BAK-treated lenses as compared to 
control (no BAK). 
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Figure IV-9 Back vertex distance variability for combination BAK plus UV-treated 




Figure IV-10 Back vertex distance variability for combination BAK plus UV-treated 
lenses, as compared to UV-treated lenses. 
 
 
Figure IV-11 Back vertex distance variability for lenses treated independently with 




Figure IV-12 Back vertex distance variability for lenses treated independently with 
BAK 0.005% solution or a combination treatment with BAK 0.005% plus UV. 
 
Figure IV-13 Back vertex distance variability for lenses treated independently with 




5.1 Key findings 
This study evaluated the combined toxicity of BAK and UV radiation on the bovine lens. The 
research was prompted by recent work demonstrating that that BAK is able to penetrate the 
eye as deep as the anterior lens,23 and that the combined effects of BAK and UV on HCEC 
lines can be additive or synergistic.11 Our results confirmed those of previous work, that 
treatment with a BAK solution or UV radiation independently reduced both cellular 
metabolic activity and optical quality. The response to BAK exposure was concentration-
dependent. Treatment with a 0.01% BAK solution significantly reduced both optical quality 
and metabolic activity. Exposure to a 0.005% BAK solution produced toxicity to lens 
metabolism, while optical function was conserved. Treatment with a 0.001% BAK solution 
did not produce lens damage in these experiments. The combined treatment of BAK and UV 
produced toxicity to the lens at all concentrations of BAK, and demonstrated a dose-response 
relationship in that reductions in optical quality were detected earlier with the highest 
concentration of BAK. However, the metabolic activity of lenses treated with both BAK and 
UV was not significantly different from those exposed to BAK alone, and similarly BVD 
variability for the combined treatment group was not statistically different from UV-treated 
lenses. The assays together indicated that significant reductions in metabolic activity 
preceded changes in optical quality. 
The results of this study replicated in part those obtained from previous research by 
our group evaluating the individual toxicity of BAK and UV on the bovine lens. For the 
effects of BAK, Youn et al. also demonstrated the concentration-dependent response of the 
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lens.22 The study found similar timing for the onset of lens metabolic activity damage from 
exposure to BAK 0.01% solution at 24 hours post-exposure, as compared to the day 2 time 
point of the current study. Youn et al. also noted that BAK 0.001% exposure did not 
significantly decrease optical quality as compared to control.22 In this study, BAK 0.001% 
did not produce significant toxicity to lens metabolic activity or optical quality. This result 
contrasts in part with the same previous study, where BAK 0.001% significantly reduced lens 
metabolic activity, measured from 72h post-exposure. The difference can be attributed to the 
exposure duration, which was 50% longer than in the current study. 
For UV exposure, Youn et al.22 exposed lenses to a UVB radiation source, as 
compared to the combined UVA and UVB spectrum in this study. However, both studies 
report significantly increased BVD variability compared to control at 14 days post-exposure. 
Our study also confirmed the previous finding that changes in metabolic activity of the lens 
are detected earlier than changes in optical quality, independent of the treatment conditions.22 
This research performed by Xu et al. suggested that BAK and UV interact to produce 
additive and synergistic effects on human corneal epithelial cell lines.11 The study found that 
BAK 0.005% and BAK 0.001% combined with UV produced additive and synergistic effects 
on metabolic activity, respectively. The findings were consistent irrespective of the treatment 
order.11 Conversely, our study demonstrated that the effect of combined BAK and UV 
exposure on lens metabolic activity was not significantly different than the effect of BAK 
alone. This was demonstrated when the lens was treated first with BAK followed by UV. It is 
notable that the synergistic and additive effects on HCEC were observed at relatively low 
doses of BAK. BAK 0.001% did not produce significant toxicity to the bovine lens in the 
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current study. Neither an additive nor synergistic reaction would be expected from combined 
exposure if the dose of BAK was not sufficient to produce toxicity. UV also did not have a 
potentiation effect on low dose BAK in these experiments. Withrow et al. also reported 
additive toxicity for BAK and UVA on mouse lymphoma cell survival and mutation 
frequency.41 A key difference between the two formerly mentioned studies evaluating 
combined toxicity and the current study was the use of mouse lymphoma and immortalized 
human corneal epithelial cell lines, as compared to whole primary tissue. A mouse 
lymphoma cell line represents a marked divergence from the nature of lens cells of bovine 
origin. For immortalized cell lines, the genotype must be transformed from primary cells in 
order to produce the occurrence of infinite generations of cells. A number of alternate 
functions are reported in immortalized cell lines as compared to primary cells, including 
altered production and responses to cell mediator molecules, growth kinetics, and respiration 
decoupling.42 An additional concern with the growth of immortalized cells is the possibility 
that through the multitude of generations of cells, further drift from the primary cell genotype 
will occur. Possible reasons for the difference in the effects of BAK and UV on HCEC as 
compared to whole lenses can be attributed to the structural organization of lenses as 
compared to suspended cells, as well as the differences that exist between whole lenses and 
immortalized cells. These differences affect the mechanism of toxicity, as described below. 
The findings from this study emphasize the importance of reproducing experiments in 




5.2 Mechanisms of toxicity 
Benzalkonium chloride is a quaternary ammonium salt, with a long hydrophilic hydrocarbon 
chain and cationic head group. It is classified as a surfactant compound, and behaves as a 
detergent in an aqueous solution.22 Its unique structure imparts superior antimicrobial 
properties, stability in solution, and allergic tolerance as compared to other preservatives.20-23, 
25, 43 However, BAK-preserved solutions are also reported to induce greater toxicity.21, 44 The 
adverse effects of BAK to structures of the anterior segment have been thoroughly reported. 
BAK is known to disrupt the tear film, the corneal epithelium, stroma and endothelium, and 
conjunctival cells. 24, 45-47 Though the potential side effects are well known, the exact 
biological mechanism by which BAK induces toxicity has not been defined. Several in vitro 
studies however have demonstrated the participation of certain biological pathways during 
BAK toxicity. A recent study by Datta and colleagues found that BAK lowered 
mitochondrial oxygen consumption and adenosine triphosphate (ATP) activity at the level of 
mitochondrial complex I in corneal epithelial cells.48 Another study performed using Chang 
conjunctival cells found that BAK was associated with H2O2 and superoxide anion 
production.47 This study suggested that the processes of free radical production, 
inflammation, and apoptosis in ocular tissue are interconnected.47 Dutot and colleagues 
examined the effects of BAK on the activation of the P2X7 death receptor found in corneal, 
conjunctival, lens, and retinal epithelial cells. The P2X7 receptor can be activated through 
interaction with reactive oxygen species, and is thought to prompt production of 
inflammatory cytokines, particularly interleukin-1 (IL-1) and interleukin-6 (IL-6). The results 
indicated that P2X7 receptor activity increased in response to BAK for ocular surface 
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epithelia.49  Another study using cultured lens epithelial cells treated with BAK induced 
production of inflammatory markers, particularly PGE2, IL-1, and IL-6.50 BAK exposure also 
reportedly activates the canonical Wnt signaling pathway, as determined by Zhou et al. 
(2011) from experiments on corneal epithelial cells lines and rat corneas.51 Other reports of 
BAK toxicity have commented that the long BAK hydrocarbon tail which improves the 
penetrative properties of preserved solutions additionally permits interaction with the lipid 
layer of the tear film and cellular membranes. BAK disperses membrane lipids which 
consequently triggers cell component leakage and lysis.52 The results of the current study, in 
which lenses do not recover in from decreases in metabolic activity or optical quality after 
exposure to BAK 0.01%, are consistent with this account, since cell lysis would reduce the 
overall cell number and thus impede both metabolic activity and cell recovery mechanisms. 
UV radiation induces photochemical damage to the eye through both direct and 
indirect mechanisms.14 The direct mechanism involves the absorption of UV light by cellular 
chromophores, including nucleic acids and proteins. The indirect mechanism of UV damage 
to the lens involves the generation of reactive oxygen species and free radicals, causing 
peroxidation of cellular lipids, and modification of DNA and proteins.13 UVB reportedly 
produces damage primarily through the direct pathway, while UVA produces damage 
through the indirect pathway.14 The consequences of UV damage to the lens often indicate 
oxidative stress. 
The anterior lens epithelium is the site of initiation for several events of UV-induced 
toxicity and cataract. The anterior location consequently involves receiving the greatest 
exposure level of UV within the lens. Reactive oxygen species and free radicals are known to 
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target the phospholipids and proteins of cellular membranes. These events result in 
dysregulation of the ionic balance of the lens, particularly the balance of Ca2+ ions.18 This 
could also lead to the aggregation of lens crystallin proteins.18 The lens epithelium 
additionally contains most of the organelles contained within the lens, including nuclei and 
mitochondria. Consequently, the epithelium is a major site of enzyme production and 
metabolic activity. Damage to lens nuclei may be produced from the formation of pyrimidine 
dimers. A study by Bantseev on lens, retinal, and corneal epithelial cell lines demonstrated 
that UVB produced shrunken nuclei. As UV produces cellular dysfunction, apoptosis may be 
induced and the extracellular spaces between lens fibre cells may be altered, producing 
changes in refractive index and loss of transparency.53 Another study reported lack of 
mitochondrial movement and fragmentation of mitochondria after irradiation of bovine 
lenses and retinal pigment epithelial cells with UVB.54 Disturbance of cell mitochondria 
would then inhibit the production of cell energy as ATP. 
The results from this study suggest that BAK and UV light in the range of 280 to 400 
nm do not interact to enhance the independent toxicities of one another on whole lenses. This 
finding is consistent with information published by Withrow and colleagues and the Japanese 
pharmacopeia, which report that BAK does not absorb wavelengths of light greater than 290 
nm.41, 55 Xu et al. also performed a photoreactivity test between BAK and UV (280 – 400 
nm), wherein cells were exposed both to UV-treated and untreated BAK. The results 
indicated that the toxicity of UV-treated BAK was similar or slightly lower than untreated 




The present study met the threshold of toxicity for both BAK and UV, at a level of 
approximately 20% reduced activity as compared to control, to permit the observation of 
additive or synergistic effects. If the reduced metabolic activity of the lens reflected having 
reduced the overall number of live cells, the expected result for two damages would be 
additive. It is likely then that the cells were damaged and rendered less functional, but not 
necessarily necrotic after each exposure. Moreover, an additive effect would not be expected 
if the cells vulnerable to BAK were the same vulnerable to the effects of UV. The current 
study evaluated the metabolic activity of cells, which for the lens is carried out by the 
mitochondria found in the epithelium and superficial cortical fiber cells. Studies of bovine 
and rat lenses demonstrated that the mitochondria in lens epithelial cells and superficial 
cortical fiber cells are distinct.56, 57 Lens epithelial cell mitochondria are densely concentrated 
surrounding the cell nucleus. In contrast, the mitochondria found in superficial cortical fiber 
cells are longer, are less densely concentrated, and not associated with the cell nucleus. 56, 57 
A study led by Bantseev and colleagues evaluated the effect of sodium dodecyl sulfate (SDS) 
on the bovine lens.58 Similar to BAK, SDS possesses a long hydrocarbon tail with an ionic 
head, which in slight contrast to BAK is negatively charged. The analysis found that SDS 
reduced mitochondrial number and length in the epithelium and superficial cortical fiber 
cells. Superficial cortical fiber cells were particularly vulnerable to the effects of SDS. 
Another study which evaluated the mechanism of damage of BAK on mitochondria found 
that cells with a mitochondrial DNA point mutation were particularly susceptible to BAK.48 
Further research is needed to confirm that the superficial cortical cells are particularly 
vulnerable to the effects of BAK and UV. This hypothesis is potentially consistent with the 
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results of previous work by our group using HCEC, which found synergistic and additive 
effects of BAK and UV. Unlike whole lenses which possess cellular and mitochondrial 
heterogeneity, the cell culture of the previous study was likely more uniform. The combined 
effects of BAK and UV on lens epithelial cell lines were not examined as part of this study; 
this is a potential avenue for further investigation how BAK and UV interact with the lens, as 
well as in different cell cultures. Further research would also be required to confirm the 
nature of combined toxicity of BAK and UV in vivo. Unlike the conditions of the current in 
vitro test, the eye in vivo would significantly dilute the concentrations of BAK tested through 
blink action and transportation through circulation. 
5.3 In vitro assessment of ocular toxicity with the bovine lens 
The Draize test is the current in vivo standard for assessing the ocular irritancy and toxicity. 
The test is performed by administering a 0.5 mg or mL of a test substance to the skin or 
lower conjunctival sac of an alert animal, typically an albino rabbit. The conjunctiva, cornea, 
and iris are monitored over time for symptoms of damage, and are ranked by the observer. 
However, this test has been criticized for several reasons in the scientific literature. A review 
by Wilhelmus reports that rater judgments are subjective, consequently producing significant 
intra-rater and inter-rater variability.38 The test is also weakly sensitive and results are not 
consistently replicable.38 Moreover, the associated animal discomfort and pain raises ethical 
concerns. Considerable effort has been put forth in developing in vitro models to reduce 
reliance on the Draize test for toxicity testing. Yet, there is no single or battery of tests which 
are validated and universally accepted to supersede the Draize test as the standard for 
assessing ocular toxicity. Further, despite the significant role that the lens performs with in 
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focusing light to the retina, there is no component of the Draize test which evaluates the 
toxicity of the test substance to the lens. 
The bovine lens, cornea, and conjunctiva are embryologically-derived from surface 
ectoderm; similar to human embryological development.59 The bovine lens also possesses 
similar physiology and morphology to the human cornea.22 The current model uses a serum 
supplement for the lens culture medium which is of the same animal origin as the culture 
tissue. The bovine lens has been previously reported as a suitable model for assessing the 
toxicity for surfactants, alcohols, UV exposure, and other xenobiotic substances.22, 58-60 The 
bovine lens performs consistently between samples in the alamarBlue and ScanTox assay, as 
shown in Tables IV-1 and IV-4. Unlike excised corneas in culture, the lens is capable of 
retaining its refractive function. The results of this study suggest that the bovine lens model is 
suitable for assessing the effects of combined toxic exposures. 
A valuable in vitro alternative to the Draize test would perform a sensitive, objective, 
valid, reliable, low-cost, robust, and specific assessment of cell viability.61 The alamarBlue 
assay is a non-toxic indicator of cell metabolic activity. The indicator is metabolized through 
reduction and oxidation mechanisms concentrated within cell mitochondria for its reduction 
from resazurin to resorufin.61 This chemical reaction yields a product with measurable 
fluorescence and absorbance, and colour change from blue (resazurin) to pink (resorufin). 
The alamarBlue assay is reported to have greater sensitivity to cell activity than similar 
assays such as MTT.62 Additionally, the MTT protocol involves a solubilization step to 




An ideal method for the evaluation of cytotoxicity in vitro would thus involve a 
battery of assays. Previous work has demonstrated that metabolic activity is well-correlated 
with induction of lens optical disturbance.63 The ScanTox assay is a non-intrusive evaluation, 
performed without the need to directly handle lenses or remove them from their culture 
medium. This method is capable of long-term lens culture, while maintaining optical 
integrity and refractive function. This may be ideal for the evaluation of toxicity of 
benzalkonium chloride and similar compounds, whose partially lipophilic nature may bind to 
ocular tissues and produce delayed effects. This also lends itself well to the study of UV 
toxicity, which was observed in this and previous studies by our group to exhibit a latency 
period.22 The system is additionally capable of monitoring recovery from the effects of UV 
radiation and cold cataract.64, 65 Long-term tissue culture is useful for measuring toxicity as 
repair mechanisms are effected.60 This study used this method for a period of 20 days, though 
it has been reported to be sustainable up to 1000 hours.60 The control lenses in this study 
were cultured successfully with consistent optical performance, and with low variability 
between samples. The results of the current study reproduced the assessments of toxicity for 
BAK and UV from previous studies well, and the control data between the studies are 
comparable.22 As an alternative to the use of live animals, which require additional 
maintenance, the use of abattoir-supplied lenses provides an accessible and low-cost test for 
ocular irritancy. The consistently of results can be attributed in part to the objective 
measurements produced by an automated laser-scanner, in contrast to judgments made by 
multiple observers.  
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In summary, the results of this study suggest that combined exposure to BAK and UV 
does not produce a significant interactive toxicity on the lens. The study confirmed previous 
work which has examined the concentration-dependent nature of BAK damage, and the 
latent effects of UV on the lens.11, 22 This work also suggests that the ideal method for 
assessing toxicology in vitro for individual and combined exposures is multifaceted, 
including work with cell lines and primary tissue, and using multiple assay types. Metabolic 
activity and optical quality together provide an effective assessment of lenticular toxicity 
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